Arthritis Therapeutics Market to 2018 Report Available From MarketResearchReports.in

Report provides key information and analysis of the Asia Pacific coal mining industry, comprising Australia, China, India, Indonesia, Kazakhstan, New Zealand, Thailand and Vietnam

Bangalore, India (prHWY.com) May 23, 2012 - The fast-growing drugs market for arthritis is expected to develop further during the coming years as companies rush to cater to rising incidence rates, according to a new report by pharmaceutical experts Research.

The new report* examines how arthritis therapeutics are becoming a gigantic attraction in the global pharmaceutical industry as the condition is increasingly considered to be one of the most common causes of disabilities.

Rising incidence rates of osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are all accelerating growth in the arthritis therapeutics market, attracting major global pharmaceutical and biotechnological companies keen to make investments in this lucrative industry.

Pfizer, Amgen, Merck, Roche and Novartis have already upped their research and development efforts in the field, with the pipeline for arthritis already demonstrating several promising therapies. The current pipeline includes many small molecule drugs and biologic therapies, as well as the first oral Disease-Modifying Antirheumatic Drug (DMARD), Tofacitinib, by Pfizer. Patients may not even have to wait for these drugs to reach shelves, as 10% of the market's prospective drugs were already in the late stage of development by the end of 2011.

A major trend in the arthritis market is the expansion of biologics as a treatment option. Biologics are prescribed for most arthritis indications, and, with the increased incidence of disease, biologics will drive the growth of the arthritis therapeutics market further during the coming years. Competition will be fierce for manufacturers, however, as the rapid entry of new players and the highly active pipeline will intensify the tussle for market share in the global arthritis market.

It's not all bad news for existing market leaders though, as some companies are being allowed to keep their patents. Following a number of court proceedings between Amgen and the Food and Drug Administration (FDA), the patent of blockbuster drug Enbrel has been extended to 2028. Other well-established therapies have also been allowed to keep their patents, including second-line RA treatment Actemra. However, patents are due to expire during the forecast period for major drugs such as Rituxan (Rituximab), Remicade (Infliximab), Celebrex (celecoxib) and Humira (adalimumab).
The global arthritis therapeutics market was estimated at $20.6 billion in 2010, and is expected to reach $35.8 billion in 2018 after increasing at a compound annual growth rate (CAGR) of 7.2%.
*Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
This report provides an expert insight into the global arthritis market and market forecast until 2018, including in-depth analysis of the top four arthritis therapeutic indications: osteoarthritis, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Furthermore, it also includes the market forecasts and treatment usage patterns of these four therapeutic indications. The report also explores the competitive landscape of the top companies in the market, and gives an analysis of the key trends in mergers and acquisitions, and licensing agreements involving arthritis therapies.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by Research's team of industry experts.

Buy this Market Research Report: Arthritis Therapeutics Market to 2018

About MarketResearchReports.in ;

MarketResearchReports.in is an e-commerce platform that specializes in distributing market research reports published by leading global market research firms through a secure online medium. It uses the best-in-class online website user interface while working continuously to make the website more and more insightful and easy to navigate with various other functionalities. MarketResearchReports.in covers the latest data on international markets, regional markets, major industries, the top companies, new products and the latest trends, both in electronic and print format. These also include reports, newsletters, country and company profiles etc.

###

Tag Words: market research, market to 2018, arthritis therapeutics

Categories: Reports

Press Release Contact
No. 579, Ground Floor, 16th Cross,
10th Main, ISRO Layout
560078
Bangalore
Karnataka
India
Press Contact - Christy D'Costa
Phone : +91-80-26860858
Fax : +91-80-26860844

Link To This Press Release:

URL HTML Code